Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Mateja, Krajc"'
Autor:
Ksenija Strojnik, Vita Setrajcic Dragos, Srdjan Novaković, Vida Stegel, Ana Blatnik, Mateja Krajc
Publikováno v:
Breast Cancer Research and Treatment
Purpose To analyze the prevalence of pathogenic/likely pathogenic variants (P/LPVs) in BRCA1 and BRCA2 genes in the largest cohort of Slovenian male breast cancer (MBC) patients to date and to explore a possible correlation between the Slovenian foun
Autor:
Barbara Gazic, Tea Nizic-Kos, Vida Stegel, Nikola Besic, Srdjan Novaković, Ana Blatnik, Petra Škerl, Mateja Krajc
Publikováno v:
Annals of Surgical Oncology. 28:2561-2570
Currently, data on pathogenic variants in the CHEK2 gene and their impact on cancer risk are lacking. This study aimed to explore the characteristics of breast cancer (BC) patients from families with CHEK2 pathogenic variants in Slovenia. In the year
Autor:
Vida Stegel, Barbara Gazic, Mateja Krajc, Ana Blatnik, Andraz Perhavec, Srdjan Novaković, Sebastijan Merlo, Andreja Gornjec
Publikováno v:
Radiology and Oncology, Vol 54, Iss 2, Pp 180-186 (2020)
Radiology and Oncology
Radiology and Oncology
Background We assessed the prevalence, localization, type and outcome of occult cancer at risk-reducing salpingo-oophorectomy or salpingectomy (RRSO) in asymptomatic carriers of pathogenic or likely pathogenic BRCA1/2 variants and high-risk BRCA1/2 n
Publikováno v:
European journal of surgical oncology, vol. 47, no. 8, pp. 1900-1906, 2021.
European journal of surgical oncology, str. 1900-1906, Vol. 47, no. 8, Aug. 2021
COBISS-ID: 6045447
European journal of surgical oncology, str. 1900-1906, Vol. 47, no. 8, Aug. 2021
COBISS-ID: 6045447
Objectives. Risk-reducing mastectomy (RRM) is one of key prevention strategies in female carriers of germline BRCA pathogenic/likely pathogenic variants (PV/LPV). We retrospectively investigated the rate, timing and longitudinal trends of bilateral R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a845e751a5beae9844a5fe6078e91c44
https://dirros.openscience.si/Dokument.php?id=20594&dn=
https://dirros.openscience.si/Dokument.php?id=20594&dn=
Autor:
Natalija, Klopčič, Simona, Hotujec, Tina, Kerševan, Ana, Blatnik, Ksenija, Strojnik, Mateja, Krajc
Publikováno v:
Onkologija; Dec2021, Vol. 25 Issue 2, p24-33, 10p
Autor:
Barbara, Babuder, Simona, Hotujec, Ana, Blatnik, Ksenija, Strojnik, Marta, Banjac, Srdjan, Novaković, Mateja, Krajc
Publikováno v:
Onkologija; Dec2021, Vol. 25 Issue 2, p16-23, 8p
Autor:
Svetlana, Novak, Simona, Hotujec, Ksenija, Strojnik, Ana, Blatnik, Erik, Škof, Maja, Ravnik, Srdjan, Novaković, Mateja, Krajc
Publikováno v:
Onkologija; Dec2021, Vol. 25 Issue 2, p6-14, 9p
Publikováno v:
Radiology and oncology (Ljubljana)
Radiology and Oncology, Vol 51, Iss 2, Pp 187-194 (2017)
Radiology and Oncology
Radiology and Oncology, Vol 51, Iss 2, Pp 187-194 (2017)
Radiology and Oncology
Background In Slovenia like in other countries, till recently, personal history of epithelial ovarian cancer (EOC) has not been included among indications for genetic counselling. Recent studies reported up to 17% rate of germinal BRCA1/2 mutation (g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9331e72cbe1d73556814a6ea0e961cbc
http://www.dlib.si/details/URN:NBN:SI:doc-HNR8ZK8L
http://www.dlib.si/details/URN:NBN:SI:doc-HNR8ZK8L
Autor:
Janez Zgajnar, Mateja Krajc, Katarina Lokar, Srdan Novakovic, Barabara Cernivc, Jacques De Greve, Erik Teugels, Nikola Besic
Publikováno v:
Vrije Universiteit Brussel
Male breast cancer (MBC) is a rare disease, comprising less than 1% of breast cancer patients in Slovenia. Some inherited cases are due to the mutations of BRCA1 or BRCA2 genes. There is no information available about the frequency of BRCA gene mutat